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http://www.darujps.com/content/20/1/101RESEARCH ARTICLE Open AccessInduction of G1 cell cycle arrest and cyclin D1
down-regulation in response to pericarp extract
of Baneh in human breast cancer T47D cells
Parisa Fathi Rezaei1,2, Shamileh Fouladdel1,3, Seyed Mahmood Ghaffari4, Gholamreza Amin5 and Ebrahim Azizi1*Abstract
Background and the purpose of the study: Natural products from plants have an important role in the
development and production of new drugs mainly for cancer therapy. More recently, we have shown that the
pericarp methanolic extract of Pistacia atlantica sub kurdica (with local name of Baneh) as a rich source of active
biological components with high antioxidant and radical scavenging activities, has ability to cease proliferation and
induce apoptosis in T47D human breast cancer cells. The present study aimed to clarify whether Baneh extract able
to alter cell cycle progression of T47D cells or not.
Methods: In order to study the possible effect of Baneh extract on cell cycle of T47D cells, we evaluated cell cycle
distribution and its regulatory proteins by flow cytometry and western blot analysis respectively.
Results: Baneh extract induced G0/G1 cell cycle arrest in conjunction with a marked decrease in expression of cyclin
D1 and cdk4 that was strongly dependent on time of exposure. In parallel, Dox-treated T47D cells in early time
points were accumulated on S phase, but after 48 h cell cycle progression was inhibited on G2/M. Dox promoted
striking accumulation of cyclin B1 rapidly and enhanced cyclin A abundance.
Conclusion: Taken together, our results establish that the antitumor activity of the pericarp extract of Baneh partly
is mediated via cell cycle arrest and downregulation of cyclin D1 and cdk4 expression. These findings warrant
further evaluation regarding the mechanism(s) of action of this promising anticancer agent.
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Breast cancer is one of the most common cancers in
women worldwide and Iran in particular. Each year over
1.15 million women are diagnosed with breast cancer
and nearly half of them die [1]. Thus, new therapeutic
steps should be taken both to prevent the development
of cancer and to lower mortality rates related to it.
The characteristic feature of tumor cells is uncontrolled
cell growth as a result of alterations in a variety of mole-
cules and regulatory pathways involved in cell cycle con-
trol [2]. Mitogenic signals induce cyclin D1 expression
and binding to cdk4/ or cdk6 in G1 phase of the cell cycle.
Then cyclin E/cdk2 activated in late G1 phase. Cdk2 forms* Correspondence: aziziebr@tums.ac.ir
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reproduction in any medium, provided the orcomplex with cyclin A in S phase to induce proteins
which involved in DNA replication. Cdk1/cyclin A is ne-
cessary for initiation of prophase and finally cdk1/cyclin B
complex takes part in and completes mitosis [3].
Lately, a significant increase has been seen in the search
for new effective cancer chemopreventive and chemother-
apeutic agents, particularly for those that have a natural
origin and relatively low toxicity [4]. Polyphenolic com-
pounds, in addition to their antioxidant activity, could
regulate the genes that are critical for the control of prolif-
eration, cell cycle and apoptosis in cancer cells. Based on
epidemiological and preclinical data, polyphenolic phyto-
chemicals possess cancer chemopreventive properties [5].
The cancer preventive effects of polyphenols are due to
the regulation of signaling pathways including; nuclear
factor-kB (NF-kB), activator protein-1 (AP-1) or mitogen-
activated protein kinases (MAPK) [6].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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natives, is an Iranian plant from Anacardiaceae family;
grow in large populations in the western, central and
eastern parts of Iran. Its nuts are used by the natives
and its gum is used in the production of chewing gum
[7]. Pistacia species has medicinal applications in different
countries [8]. Only phytochemical analysis and apoptosis
induction of Baneh pericarp extract on T47D and HT29
cells were reported by our group [9,10]. A wide range of
investigations have exhibited anticancer potency of mastic
gum of P. lentiscus var. chia in different cell culture sys-
tems including; prostate cancer, colon cancer, human colo-
rectal xenografts, leukemia and Lewis lung carcinoma [9].
In view of the previously mentioned effects of Baneh
extract on cell viability and apoptosis induction of T47D
cells, we investigated whether the Baneh extract is
involved in cell cycle progression of T47D cells.
Materials and methods
Materials
RPMI 1640 and FBS were obtained from Biosera (East
Sussex, UK). Pen-strep and Trypsin-EDTA were pur-
chased from Gibco (Paeiley, UK). Doxorubicin (EbeDoxo)
was purchased from Ebewe (Unterach, Austria). Methanol
was obtained from Merck (Darmstadt, Germany). The
cell culture petridishes were obtained from Greiner
Bio-one (Frickenhausen, Germany). DAPI (4,6-diamidino-
2-phenylindole) and Nonidet P40 were purchased from
Roche (Mannheim, Germany).
Plant materials and extraction
Fresh unripe fruits from P. atlantica subsp kurdica were
gathered from Kurdestan province of Iran in June and
recognized by Dr. Amin, Department of Pharmacy, Tehran
University of Medical Sciences (6673-THE). The pericarp
methanolic extract of Baneh and its working concentrations
were prepared as previously described by our group [9].
Cell culture
The human breast cancer cell line T47D (ATCC, HTB-
133) was obtained from Pasteur institute (Tehran, Iran)
and maintained in RPMI 1640 medium supplemented
with 10% heat-inactivated fetal bovine serum, 100 μg/ml
streptomycin and 100 U/ml penicillin under conditions
of 5% CO2 atmosphere at 37°C.
Cell cycle analysis
DAPI staining was used to determine the distribution of
cells in different phases of the cell cycle by flow cytome-
try analysis [11]. Briefly, cells were treated with IC50 of
Baneh extract (1 mg/ml) and Dox (250 nM) which was
previously determined and reported by our group [9].
Treated and untreated cells were trypsinized, resus-
pended in DAPI staining solution and analyzed by Partecflow cytometer then data analysis was done using
FloMax software.
Western blotting
Alteration in cell cycle regulatory proteins in presence of
the Baneh extract and Dox was investigated by western
blot as previously explained [12]. Briefly, the cells were
lysed in lysis buffer. Then the total proteins were elec-
trophoresed on a 12% SDS-PAGE, transferred to nitro-
cellulose membranes (Amersham pharmacia Biotech,
Germany) and probed with following primary antibodies:
mouse monoclonal cyclin D1 (BD Bioscience, USA); cyclin
A, cyclin B1, cyclin E, cdk1, cdk2, cdk4, cdk6 (Santa Cruz
Biotechnology, USA) and β-actin (Sigma, Germany); rabbit
polyclonal cdk4 (Santa Cruz Biotechnology). We also used
goat-anti-mouse IgG and goat-anti-rabbit IgG (Santa Cruz
Biotechnology) conjugated to horseradish peroxidase as
secondary antibodies. Immunoreactive polypeptides were
detected by chemiluminescence using enhanced electroche-
miluminescence (ECL) reagents (Amersham bioscience,
Germany) and subsequent autoradiography.
Statistical analysis
All cell cycle analysis data were shown as mean±SE of
three independent experiments. Data were statistically
compared using one-way ANOVA with Tukey post hoc
and P<0.05 were considered statistically significant.
Results
Effects on cell cycle distribution
Flow cytometry method showed that by increasing the
time, Baneh treated cells were accumulated in G0/G1
phase compared to the control cells. Within 48 h ~ 80%
of the cells were at the G0/G1 phase versus ~58% in the
control cells. Dox exposed cells exhibited accumulation
of the cells in S and by increasing the time, the cell cycle
pattern was changed to G2/M accumulation of the cells
and after 48 h 91% of the cells were at the G2/M phase
against 19% in the control cells (Table 1).
Effects on cell cycle regulation
To further ascertain the molecular mechanisms involved
in cell cycle block of T47D cells, western blot analysis
was performed. As shown in Figure 1, the G0/G1 block
of the cell cycle in Baneh treated cells was supported by
the intensive down-regulation of cyclin D1 and cdk4,
according to the exposure time. Cyclin E protein level
was increased at early time points but strong down-
regulation of cyclin E was happened after 48 h. Also cyclin A
and cdk2 levels were decreased, but not in a time dependent
manner, showing considerable decrease at 72 h. In addition,
cyclin B1 level was decreased strongly at early time points
and approximately disappeared after 48 h. Furthermore, in
Dox-exposed cells, the G2/M delay of cell cycle progression
Table 1 Alteration in the cell cycle distribution of T47D cells
Groups 12 h 24 h 48 h 72 h
CTRL 58.44 ± 0.056 58.74 ± 0.403 58.085 ± 0.96 51.96 ± 0.056
G0/G1 B 64.63 ± 0.5
* 68.25 ± 1.9** 79.90 ± 0.91** 80.77 ± 31**
DOX 36.91 ± 2.63** 14.97 ± 0.45** 4.59 ± 0.69** 3.95 ± 0.11**
CTRL 23.35 ± 0.42 25.39 ± 1.86 22.92 ± 2.54 28.45 ± 2.27
S B 24.99 ± 1 21.25 ± 0 12.85 ± 1.04* 12.17 ± 0.67**
DOX 34.71 ± 1.45 49.69 ± 2.55* 4.98 ± 0.74** 4.51 ± 0.92**
CTRL 18.21 ± 0.36 15.86 ± 2.26 18.99 ± 1.57 19.58 ± 2.34
G2/M B 10.41 ± 1.45 10.88 ± 0.73 7.24 ± 0.13
* 7.05 ± 0.36*
DOX 27.93 ± 3.46 35.35 ± 2.05* 90.9 ± 2.19** 91.51 ± 1.03**
CTRL: untreated cells.
B: Baneh extract-treated cells.
All data were shown as mean ± SE of three independent experiments. Data were statistically compared using one-way ANOVA with Tukey post hoc and P<0.05
were considered statistically significant.
*p<0.05 and **p<0.001 in comparison to control RPMI (CTRL).
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comparison to the control cells. Cdk1 protein expression level
showed strong increase within 24–48 h in comparison to the
control cells. On the other hand, cyclin A and cdk2 levels in
Dox exposed cells were higher than control cells. The expres-
sion of cdk4 and cdk6 were quietly similar to their expression
in control cells. Dox induced upregulation of cyclin E at early
time points but its expression was decreased after 48 h. Cyc-
lin D1 expression in Baneh treated cells was higher than its
expression in control cells within 12 and 24 h but was
reduced after 48 h (Figure 1).CTRL           B                      Dox










Figure 1 Expression of cell cycle-regulatory proteins. Cells were
treated with RPMI (CTRL), Baneh 1 mg/ml (B) and Dox 250 nM for
12–72 h. Expression of cell cycle-regulatory proteins for indicated
time points were analyzed by western blotting. B-actin is showed as
loading control. A representative experiment of three independent
experiments is shown.Discussion
Chemotherapeutic approach which uses various natural
(plant-derived) agents has become the focus of wide-
spread attention for managing cancers in recent years; it
is hoped that such studies will show a positive outcome
to provide a scientific basis as to being efficient and
useful in chemoprevention/chemotherapy of various
cancers.
Reduction in metabolic activity of the cell is due to re-
duction in number of the cells for cell cycle block and/
or cell death. Since the 30% induction of apoptosis in
Baneh-treated T47D cells could not be enough to ex-
plain the reduction in cell viability observed with MTT
assay, we decided to check the effect of Baneh extract
on the cell cycle progression.
Uncontrolled cell cycle has a pivotal role in cancer in-
cidence. Our results demonstrated that Baneh extract
blocked the cell cycle in G0/G1 phase in a time
dependent manner up to 48 h (Table 1) accompanied by
down regulation of positive regulators of G1/S transition
including cyclin D1 and cdk4, depending on the time of
exposure (Figure 1).
With respect to the phytochemical evaluation, the ex-
tract possesses considerable amounts of polyphenolic
compounds including flavonoids and anthocyanins [10].
Dietary flavonoids inhibit the proliferation of various
cancer cells and tumor growth in animal models [5]. Re-
cent studies have shown that polyphenols directly or in-
directly can inhibit different cells at different cell cycle
phases [6]. Recently, S phase delay of Baneh-treated
HT29 cells was reported by our group [10]. Pc-3 (pros-
tate cancer cells) treated with gum mastic of P. lentiscus
showed cyclin D1 downregulation and G1 block of the
cell cycle [13]. Treatment of LNcap cells with Gum mas-
tic led to downregulation of cyclin D1 [14]. HCT116-
treated cells with chios mastic gum (CMG) were shown
G1cell cycle arrest [15]. It is established that a single
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kinases [16].
Polyphenolic compounds have phytoestrogenic activity
[17]. T47D cells are known as ER+ (Estrogen Receptor)
cells [18]. Estrogenic estradiols, act through the regula-
tion of expression and function of the G1 phase regula-
tory proteins and promote transition through G1 phase.
Cyclin D1, c-Myc, p21 and cyclin E-cdk2 are estrogen
downstream targets [19]. Estradiol can increase cyclin
D1 expression by stimulating cyclin D1 transcription via
PI3-Kinase/Akt pathway [20]. The inhibitory effect of
anti-estrogens on estrogen receptor activity leads to
decreased cyclin D1 expression and dissociation of p21
and p27 from the cyclin D1-cdk4/6 complex then associ-
ation with cyclinE-cdk2 complexes [21]. Because of the
promoting effects of estrogen on expression of the cyc-
ling D1, it is conceivable that Baneh extract involves
component(s) which act as anti-estrogenic agent in
T47D cells. It has been established that anti-estrogen
treatment of MCF7 breast cancer cells induced reduc-
tion of c-Myc expression, resulting in cyclin D1 downre-
gulation and eventually cell cycle arrest [19]. In
tamoxifen-treated T47D cells, G0/G1 delay of cell cycle
was reported [22]. Cyclin D1 expression and p53 status,
both at the gene and protein level, revealed a highly sig-
nificant association. Cyclin D1 may be one of the down-
stream effectors of p53 [23]. Loss of G1/S control and
loss of p53 are two serious factors in tumor formation
which directly affect cell-cycle checkpoints [24]. The sta-
tus of p53 and ER affect the response of breast cancer
cells to exogenous agents. T47D cells express mutated
and nonfunctional form of p53 [25].
It is reported that NF-κB promotes G1-to-S phase
transition in mouse embryonic fibroblasts and in T47D
carcinoma cells. Inhibition of NF-κB induces pRb phos-
phorylation and inhibits G1-to-S phase transition. NF-κB
can functionally interact with other transcription factors
which regulate cyclin D1 promoter including; c-Fos/c-
Jun, SP1, E2F1 [26]. According to the findings, inhibition
of signal transduction proteins in the pathways linked to
activation of NF-κB, in part is responsible for the cell
cycle arrest and remarkable cyclin D1 reduction induced
by Baneh extract in T47D cells.
Cyclin D1 is amplified and or overexpressed in a sub-
set of human cancers including breast cancer [27]. Due
to the astonishing downregulation effect of Baneh ex-
tract on cyclin D1 abundance it could be a good candi-
date for malignancies with deregulated expression of this
protein.
Doxorubicin is one of the most common anticancer
drugs and is used for the treatment of human cancers.
The main anticancer effect of Dox is due to DNA damage
and resulting growth arrest or cell death [28]. Dox treated
cells shown G2/M type of cell cycle arrest associated withcyclin B1enhancment (Table 1 and Figure 1). Increased ex-
pression of cyclin B1 and G2/M delay of cell cycle in Dox-
treated HT29 cells was reported by our group [10].
Increased cyclin A expression, accumulation of cells at G2/
M and number of apoptotic cells in Dox-treated k562 cells
were described [29]. Maximized level of cyclin B1 pro-
tein in T47D exposed cells with Dox (10 ng/ml) has
been shown [18]. Previously, Ling et al., demonstrated
that in p388 murine leukemia cells, Dox caused G2/M
cell cycle arrest, reduced p34 kinase activity, increased
cyclin B1, alteration of cyclin B1/cdk1 complex func-
tion and/or DNA damage may trigger apoptosis [30].
Recently, induction of apoptosis in Dox-treated T47D
cells was shown by our group [9]. This is the first re-
port to show that Baneh extract can cease cell cycle
progression of T47D cells.
Conclusion
Overall, our results clearly indicate that Baneh extract as
a potent and novel natural anticancer agent able to cease
cell cycle progression of T47D cells at G0/G1 phase asso-
ciated with downregulation of cyclin D1 by increasing
the exposure time. Therefore decreased cyclin D1 ex-
pression could be a potential mechanism of growth in-
hibition by Baneh extract. Based on these findings,
Baneh extract might be a good candidate for cancer ther-
apy but further studies are necessary for in depth investi-
gations of mechanism(s) of action of Baneh extract.
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